The Industry Committee oversees the strategies and activities related to the industry and biotech members of the society. The committee aims to create networking, education and collaboration opportunities by providing a forum for those in industry to meet and discuss areas of interest that are particular to those involved in drug development and taking a product to market.
Edward Cha, MD, PhD – Genentech
Leena Gandhi, MD, PhD – Eli Lilly and Company
Israel Lowy, MD, PhD – Regeneron Pharmaceuticals
Salil Patel, PhD – Bristol-Myers Squibb
Eric H. Rubin, MD - Merck